Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6K Buy
52
+10
+24% +$1.28K ﹤0.01% 708
2026
Q2
$7K Hold
42
– – ﹤0.01% 681
2026
Q1
$3K Hold
42
– – ﹤0.01% 748
2025
Q4
$3K Hold
42
– – ﹤0.01% 755
2025
Q3
$4K Hold
42
– – ﹤0.01% 677
2025
Q2
$2K Buy
42
+28
+200% +$1.6K ﹤0.01% 773
2025
Q1
$0 Buy
+14
New +$885 ﹤0.01% 973
2024
Q4
– Sell
-10
Closed -$1K – 970
2024
Q3
$1K Buy
10
+5
+100% +$585 ﹤0.01% 741
2024
Q2
$0 Hold
5
– – ﹤0.01% 864
2024
Q1
$1K Buy
+5
New +$596 ﹤0.01% 822

Other funds holding ACLS

Avion Wealth's ACLS Position: Q3 2026 in Review

Avion Wealth increased its Axcelis (ACLS) stake by 24% in Q3 2026, buying an estimated $1.28K and bringing the position to 52 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Avion Wealth first reported a position in ACLS in Q1 2024 and has held it in 10 quarters since. The position peaked at $7K in Q2 2026. 212 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.

  • Avion Wealth held 52 shares of Axcelis worth $6K as of Q3 2026.
  • Avion Wealth bought 10 Axcelis shares in Q3 2026, an estimated $1.28K.
  • Axcelis made up ﹤0.01% of Avion Wealth's portfolio in Q3 2026, its #708 holding.
  • Avion Wealth first reported a position in Axcelis in Q1 2024 and has held it in 10 quarters since.
  • Avion Wealth's Axcelis position peaked at $7K in Q2 2026.
  • 212 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.